Skin melanocytic tumor

Congenital nevi and associated neoplasms

Proliferative nodule



Last author update: 24 September 2024
Last staff update: 24 September 2024

Copyright: 2021-2024, PathologyOutlines.com, Inc.

PubMed Search: Proliferative nodule

Nicholas Polster, M.D.
Carina Dehner, M.D., Ph.D.
Page views in 2024 to date: 24
Cite this page: Polster N, Dehner C. Proliferative nodule. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/skintumormelanocyticproliferativenodule.html. Accessed December 2nd, 2024.
Definition / general
  • Distinct cellular nodules of benign melanocytes that are found within and arise from a benign background nevus (typically congenital)
Essential features
  • Distinct cellular nodules of melanocytes found within a benign background nevus
  • Have both benign and atypical morphologies, neither of which metastasize
  • Most commonly arise from congenital nevi, especially giant congenital nevi but can also be seen in acquired nevi, such as blue nevi
Terminology
  • Synonyms: expansile and cellular nodules, nodular proliferations, atypical proliferative nodules (WHO) (Arch Dermatol 2004;140:83)
ICD coding
  • ICD-O: 8762/1 - proliferative dermal lesion in congenital nevus
  • ICD-11: 2F20.2 & XH6AH3 - congenital melanocytic nevus & proliferative dermal lesion in congenital nevus
Epidemiology
  • Often present at birth or noticed within days to weeks after (Am J Surg Pathol 2004;28:1017)
  • Frequently develop within first, second and third decades of life
Sites
Pathophysiology
  • Thought to be result of numerical chromosomal gains and losses within an existing nevus (Am J Pathol 2002;161:1163)
    • In copy number gains, causes simultaneous increased expression in genes that enhance and genes that decrease malignant potential
    • In copy number losses, causes simultaneous decreased expression in genes that enhance and genes that decrease malignant potential
  • Differs from melanoma, which can have selective increased or decreased expression in specific regions of chromosomes allowing for accumulation of mutations in genes that benefit growth, reproduction and spread while reducing expression of genes that inhibit these (Am J Surg Pathol 2011;35:656)
Etiology
  • No predisposing factors have been described
Clinical features
Diagnosis
  • Diagnosis of proliferative nodule is typically made histologically (An Bras Dermatol 2017;92:231)
  • Due to the striking histologic resemblance proliferative nodules can have to melanoma, a combination of spontaneous regression, molecular diagnostics and immunohistochemistry may be required to distinguish proliferative nodules from melanoma (Br J Plast Surg 2003;56:164)
Prognostic factors
Case reports
Treatment
Clinical images

Images hosted on other servers:
Dome shaped gray nodule

Dome shaped gray nodule

Dermoscopy of nodule

Dermoscopy of nodule

Nodules within plaque

Nodules within plaque

Gross description
  • Skin shave or ellipse with a melanocytic lesion on the surface, which may or may not have a discrete nodule or macule within
Microscopic (histologic) description
  • Nodular dermal melanocytic proliferation within a larger surrounding nevus
  • Higher cell density than the surrounding nevus and can be more mitotically active
  • Demarcation between cells of the nodule and surrounding nevus is often obvious at low power
  • Nodules are usually found in the papillary to middle dermis but can extend into the deep dermis (Australas J Dermatol 2000;41:109)
  • In rare cases they may have many mitotic figures but can later regress (Br J Plast Surg 2003;56:164)
  • Can occasionally exhibit mucinosis (Am J Surg Pathol 2011;35:656)
  • Benign proliferative nodule (Am J Surg Pathol 2011;35:656)
    • More blended than sharp demarcation between nodule and background nevus
    • No effacement of epidermis
    • Mitotic activity typically ≤ 1/mm²
    • Minimal pleomorphism
  • Atypical proliferative nodule (Am J Surg Pathol 2011;35:656)
    • Sharp demarcation between nodule and background nevus
    • Usually demonstrates pleomorphism
    • Usually exhibits expansile growth
    • Can have many mitotic figures
    • Can have nearly identical morphology to malignant melanoma
  • Distinct recurring morphologic patterns (Am J Surg Pathol 2015;39:405)
    • Epithelioid pattern
      • Most common
      • Sharply demarcated expansile nodule of epithelioid melanocytes
      • Pattern can be further stratified into 3 subcategories: classic epithelioid, monotonous epithelioid surrounding blood vessels and epithelioid with Spitzoid morphology
    • Nevoid melanoma-like pattern: poorly circumscribed proliferation of intermediate sized mitotically active melanocytes with moderate nuclear atypia confined to the dermis
    • Blue nevus-like pattern
      • Heavily pigmented melanocytes
      • Can resemble epithelioid blue nevi or cellular blue nevi
    • Small round blue cell pattern: coarse chromatin, high mitotic count, lack of prominent nucleoli, resembles Merkel cell carcinoma
    • Combination patterns consisting of any of the above patterns combined with a rare, complex pattern, such as a neurocristic pattern or dermatofibrosarcoma protuberans-like pattern
    • Other patterns, such as deep penetrating nevus-like (An Bras Dermatol 2017;92:231)
Microscopic (histologic) images

Contributed by Rachel Kowal, M.D. and Ahmed Alomari, M.D.
Small, blended proliferative nodule

Small, blended proliferative nodule

Rare dermal mitotic figures

Rare dermal mitotic figures

Enlarged melanocytes

Enlarged melanocytes

Deep penetrating nevus-like

Deep penetrating nevus-like

Spitzoid features

Spitzoid features


Numerous mitoses

Numerous mitoses

Ki67 / MelanA immunostain

Ki67 / MelanA immunostain

CD117 Immunostain

CD117 Immunostain

p16 immunostain

p16 immunostain

Cytology description
  • Cytology is not part of the work up for proliferative nodules
Positive stains
Negative stains
Molecular / cytogenetics description
Sample pathology report
  • Skin, back, biopsy:
    • Compound nevus with congenital features and focal proliferative nodule (see comment)
    • Comment: There is a compound congenital nevus with good dermal maturation. Within it there is an area of greater cellularity with larger, more hyperchromatic cells. This component appears to blend into the background nevus and does demonstrate maturation. This is favored to represent a proliferative nodule.
Differential diagnosis
  • Malignant melanoma:
    • Can evolve from preexisting nevi, especially giant congenital nevi (Br J Plast Surg 2003;56:164)
    • Genomic hybridization can show complex chromosomal aberrations, such as copy number changes, specifically partial copy number gains or losses (J Cutan Pathol 2021;48:1410)
    • In a study comparing proliferative nodules and melanomas arising from congenital nevi, melanomas (Am J Surg Pathol 2015;39:405)
      • Had an average mitotic count of 12.5 mitoses/mm2 compared to proliferative nodules average of 1.67 mitoses/mm2
      • Are more likely to have ulceration of the overlying epidermis
      • Are far less common and less likely to present as multiple lesions than proliferative nodules
  • Combined melanocytic nevi:
    • Composed of 2 distinct populations of melanocytes, typically a common nevus with an associated secondary nevus
    • Blue nevi are the most common to present in this fashion but other nevi, such as Spitz nevi and BAP1 inactivated melanocytoma, can as well (Am J Surg Pathol 2011;35:1540)
    • Blue nevus:
      • Dermal proliferation of dendritic, pigmented melanocytes with small round to oval nuclei
    • Spitz nevus:
      • Dermal proliferation of large spindled to epithelioid cells, which are more nested superficially and extend deep as individual cells
      • Can have Kamino bodies
    • BAP1 inactivated melanocytoma:
      • Predominately dermal based proliferation of large epithelioid melanocytes with characteristic biallelic inactivation of the BAP1 gene (Am J Surg Pathol 2012;36:818)
Board review style question #1

Which of the following describes melanocytic proliferative nodules?

  1. Dermal proliferation of pigmented melanocytes with dendritic morphology within a fibroblastic stroma
  2. Epithelioid to spindled benign melanocytic proliferation with biallelic inactivation of BAP1
  3. Melanocyte proliferations with cytologic atypia, invasive growth and ulceration
  4. Nodular proliferation of melanocytes that is distinct from and more cellular than a surrounding larger background nevus
  5. Proliferation of large epithelioid to spindle cells with Kamino bodies
Board review style answer #1
D. Nodular proliferation of melanocytes that is distinct from and more cellular than a surrounding larger background nevus. Proliferative nodules are nodular proliferations of melanocytes that are distinct from and more cellular than their surrounding larger background nevi. Answer B is incorrect because it describes BAP1 inactivated melanocytoma. Answer E is incorrect because it describes Spitz nevi. Answer C is incorrect because it describes invasive melanoma. Answer A is incorrect because it describes blue nevi.

Comment Here

Reference: Proliferative nodule
Board review style question #2
Which of the following would more likely be seen in a benign melanocytic proliferative nodule as compared to an atypical proliferative nodule?

  1. Blended transition from the proliferative nodule to background nevus
  2. Epidermal effacement
  3. Expansile growth
  4. Many mitotic figures
  5. Striking nuclear pleomorphism
Board review style answer #2
A. Blended transition from the proliferative nodule to background nevus. Benign proliferative nodules tend to have a more subtle blend into their background nevi, while atypical proliferative nodules often have a sharp demarcation. Answers B - E are incorrect because they describe atypical proliferative nodules. Benign proliferative nodules tend to have minimal mitotic activity and minimal nuclear pleomorphism, while atypical proliferative nodules can have many mitotic figures, striking nuclear pleomorphism and expansile growth.

Comment Here

Reference: Proliferative nodule
Back to top
Image 01 Image 02